About this trial
This study is about helping people in Qatar who have Type 2 Diabetes take better care of their health. Diabetes is a common and growing problem in Qatar, and many people need more support and information to manage it well in their daily lives.
Right now, there is a program called DESMOND in Qatar, but it is only available in a few places and can be expensive to run. It also doesn't always work well in the long term. That's why we are creating a new diabetes education program called PARADIGM-Q. This program will be easier to access, more affordable, and designed to match the culture and needs of people living in Qatar.
The PARADIGM-Q program will teach people how to manage diabetes using real-life examples and group discussions. This method is called Case-Based Learning. It helps people understand their condition better and learn how to make good decisions about food, exercise, medication, and dealing with challenges.
The project will happen in two main phases:
Phase One: Understanding and Creating the Program
In the first part, we'll look at different ways of teaching about diabetes and see if a method called Case-Based Learning (CBL) works well. After that, we'll build a curriculum (a plan for teaching) based on the PARADIGM model. This curriculum, called the PARADIGM-Q program, will use the CBL method to teach. We'll also test this new program with a small group of diabetes educators and people with diabetes to make sure it works well. Their feedback will help me make the program even better.
Phase Two: Testing the Program
In the second part, we'll do a big study using a mix of people from different backgrounds in Qatar who have Type 2 Diabetes. we want to see if the PARADIGM-Q program is better than the program they already have (called DESMOND). we'll look the impact of our new program on different things like how much they know about diabetes, how active they are, their blood sugar levels (HbA1C), and their overall quality of life.
This study could lead to a new standard for diabetes education in Qatar and other countries in the region, helping more people live healthier lives with diabetes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 to 65 years.
Diagnosed with Type 2 Diabetes Mellitus.
Most recent HbA1c ≥ 8% (within the last 6 months).
Fluent in Arabic and/or English.
Disqualifiers
Diagnosed with any type of diabetes other than Type 2.
Pregnant women.
Presence of major diabetes complications (e.g., renal failure, severe retinopathy, blindness, stroke, heart failure, cancer).
Physical or mental disabilities that would hinder participation in education sessions.
Trial design
Parallel
Treatments tested in this trial
Intervention Name: PARADIGM-Q Diabetes Self-Management Education Program
BehavioralPARADIGM-Q Diabetes Self-Management Education Program This is a culturally sensitive, structured education intervention tailored for adults with Type 2 Diabetes in Qatar. Developed using the PARADIGM model and delivered through a Case-Based Learning (CBL) approach, the program comprises three weekly group sessions of 3.5 hours each. Each session targets key self-management attributes: problem-solving, decision-making, taking action, resource utilization, and patient-provider relationships. The program emphasizes real-life applicability, cultural relevance, and skill-building to support sustainable diabetes self-care.
Control Arm (DESMOND): DESMOND Diabetes Self-Management Education Program
BehavioralThe DESMOND Diabetes Self-Management Education Program is the standard diabetes education intervention currently offered to newly diagnosed patients with Type 2 Diabetes in Qatar. It is a UK-developed, theory-driven program delivered over two group sessions, each lasting approximately four hours. The program provides structured education on diabetes, lifestyle management, and risk reduction strategies. It does not incorporate case-based learning or cultural tailoring, distinguishing it from the experimental PARADIGM-Q intervention. DESMOND is used here as an active comparator to evaluate the added value of culturally sensitive, problem-based education.
Treatment groups
Trial outcomes
Primary outcomes
Change in Glycated Hemoglobin (HbA1c)
Measurement of HbA1c to assess long-term glycemic control.
Secondary outcomes
Change in Health-Related Quality of Life
Evaluated using the Appraisal of Diabetes Scale (ADS)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ragae Dughmosh
Lead sponsor
Qatar University
Sponsor institution
Qatar National Research Fund
Collaborator
Hamad Medical Corporation
Collaborator
Primary Health Care Corporation, Qatar
Collaborator
Qatar University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: